This is Part 4 of our series on virtual agency inspections. In this part, former FDA investigator Ricki Chase provides her advice on how to host a virtual inspection. In Part 3, she provided insight into the best way to prepare for virtual inspections, including how to always be ready, how to review documents, and which documents FDA is likely to request for review.

In Part 1, former FDA executive Howard Sklamberg reviewed the current inspection landscape and what may trigger an inspection these days. In Part 2 we reviewed a state-of-the-art virtual inspection platform using mixed reality technology developed by Thermo Fisher Scientific that was presented at the ISPE Biopharmaceutical Manufacturing Conference held virtually in early June.

Sklamberg and Chase were both speakers at a mid-June webinar sponsored by the law firm Arnold & Porter, titled “FDA Inspection Alternatives During the COVID-19 Pandemic: Requesting, Preparing for and Responding to FDA Virtual Inspections.”

Get your 483 Observation Report

Establishing and Practicing Behaviors

Chase began her remarks on hosting a virtual inspection by pointing out that we all know there are certain behaviors we should exercise when we have a live, in-person inspection. Those apply to virtual inspections as well.

“A great quality system ensures constant readiness,” she maintained. “This includes practicing your inspection management. You should follow your normal processes, the ones that you are familiar with. You need to practice and follow them. Where you need to adjust for the mode of communication, make your adjustments. But do not throw everything to the wind and start from scratch just because it is a virtual inspection. Stick with what you have practiced and what you know.”

Virtual Inspection Best Practices

Designate a single point of contact (POC) for the receipt of the questions and the document requests. If you are not doing a live inspection—for example, by video conferencing, WebEx, Zoom, or something like that—they are probably going to be sending questions and document requests to you via email. Make sure you have a single point of contact for that because you do not want anything to get lost. And just like any other type of inspection, you need to make sure that you understand the requests. If you do not, ask for clarification.

You should have a standard team that participates in an inspection.

Know who your subject matter experts (SMEs) are. Make sure that the SMEs are a part of the process. One thing to consider, if they are doing a video inspection with you, is whether you want the SMEs in the room on camera. “Do they present the best to FDA? Or do you want them in the back room supporting the person who is in the room and visibly in front of the FDA on the video conference? These are things that you should normally consider in your course of preparedness for any type of inspection,” Chase maintained.

However, you cannot be assured if it is a virtual inspection that FDA will only work with a single spokesperson.  It is very possible that they will ask to speak to the person whose name is on the document—the person who authored it or the person who reviewed it. Just because it is a virtual inspection does not mean that you should not have the relevant personnel available.

“When you send a document in the room when FDA is on site, you would expect that the individuals responsible for that would be available in case they have a question. It is no different here. You need to make sure that they are available.”

When you send a document in the room when FDA is on site, you would expect that the individuals responsible for that would be available in case they have a question. It is no different here. You need to make sure that they are available.

As in your normal process, make sure you have an independent review of your documents prior to submitting them. If they are doing a video conference with you, you should be running that backroom the same way that you always do. They make a request. You review it. Remember, this is not the time to make changes to your documents.

If they have made a request to you in writing and asked you to submit certain documentation via email or standard mail, it is important that you do not go back and make changes in those documents. What you do want to do is review them and anticipate what the follow up questions may be so that you can immediately begin preparing answers for those anticipated follow up questions.

Communication is Key

It is also important when you are communicating via teleconference to remember that the investigator is listening to you, but not seeing you. Your tone and your delivery are extremely critical. You want to make sure you communicate clearly.

“I tend to be a fast speaker,” Chase said. “If you are as well, you may want to make sure that you are taking a breath and slowing yourself down, giving the investigator time to interject with questions. You want to make sure you watch your tone so that it does not seem that you are being defensive or that you are being irritated by the fact that they are trying to conduct a remote inspection.”

Finally, it is important if you are doing a video conference that you dress professionally. “We all know that it shows respect. It creates confidence in your abilities and in your organization. If you are going to be on video, make sure that you look the part of your role and responsibility.”

Make sure that if you communicate in writing—not just on the phone or on a video—that your words are chosen to be clear and concise and that you are not using any type of inflammatory language and you are not appearing to be argumentative.

“I would also like to point out that context is important,” Chase stressed. “Where you need to provide context, you should provide the context. Just ensure that you are not allowing the provision of context to now move into lengthy storytelling or unnecessary verbiage or the entire history of a situation which turns out to not be relevant or may be an overshare. Particularly if you are providing that context in writing, you need to have an extra layer of review to make sure that what you are communicating is clearly what you intend to communicate.”

Adjust Your Logistics

We have discussed having a virtual inspection, mailing/emailing documents, teleconferences, and video conferencing. These are not the normal ways that we usually work with FDA on inspections. “You need to think about what your logistics are. You need to make sure right now, today, before FDA calls you on the phone and says they are going to do an inspection, that you are ready.” 

You need to make sure that you can provide the documents in a format and file type that FDA can receive and read them in. If you are using some type of proprietary internal software and you send them a digital data file and they cannot read it, that is very frustrating for them. You do not want to frustrate them. Make sure you are communicating and understanding what they have the capability to receive and what you have the capability to send.

You need to think about what your logistics are. You need to make sure right now, today, before FDA calls you on the phone and says they are going to do an inspection, that you are ready.

Be mindful of file sizes as well. Submit your records and your data the way that they specifically ask for them, e.g., if they give you identifiers, ask you specifically to write a question number on your reply or request you to restate the question that you are answering so that they can marry the documentation up with their information, follow the request. Help them be successful in conducting the inspection.

Make sure your telephone and conferencing and videoconferencing equipment works. If you do not have I.T. on your team, engage with I.T. and start getting them in the practice of doing this and being immediately available, looking at your systems and ensuring these systems would be adequate for this type of inspection.

You want to make sure that you have your printing, scanning, and copying functions available. We take these for granted. But occasionally these things break down and you cannot get a serviceperson in there. You need to know what you have available at your fingertips to get this job done.

“Make sure that your email is considered part of the official record,” Chase advised. “And be incredibly careful about your e-mail communication. Anything that you send to the agency can become part of the official record. This includes text messages. I would strongly recommend that you do not get into a text messaging habit with your investigators. Keep it in a format which can be maintained and be official.”

Remember that when you do send an email that your email can be altered and the context could be changed. “We would never presume that anybody would do that. But we also want to protect ourselves and make sure that we are not providing opportunities. So perhaps the email says, ‘please see the enclosed.’

The context that you need to provide or the description of your documents might exist in a word document that has been approved by your team. Put that conversation or context along with the documents in a PDF format so that it is secure and becomes part of the official record,” she advised.

Finally, just like in any other type of inspection, do not record your investigator or the inspection. “If you feel so strongly that you need to do that, you certainly need to have that conversation with the investigator before things happen, because if you do they are required by policy to record as well. My recommendation is do not record. It makes things awkward and uncomfortable.”

Do not record your investigator or the inspection. ‘If you feel so strongly that you need to do that, you certainly need to have that conversation with the investigator before things happen, because if you do they are required by policy to record as well. My recommendation is do not record. It makes things awkward and uncomfortable.’

You need to maintain an inspection binder just like in any inspection. Include all the submissions to FDA at their request. Ensure that every document is cross-referenced to any electronic file or correspondence that you have provided context for so that your record is complete.  The investigators should be able to easily understand what you submitted to them. And they should understand which inquiry your response marries up to. You want to make it easy for them to follow what you sent them in response to their request.

If you are the point of contact, “now is not the time to get a little behind on your email. Make sure that you are monitoring your email and that you are very attentive to any communication you get from FDA so that you can respond in a timely way,” Chase recommended. “Minimize your email traffic internally. Make sure that you answer your telephone.” If they must call you because they are not clear about something and it is easier to discuss on the phone, you need to pick up the phone and have that conversation with them.

“You should handle this like you would any other inspection,” Chase advised. “If you have a request and the team is working in the backroom—which is where they should be—then be in the backroom or be in your conference room managing the inspection the way you normally would rather than and each of you sitting at your desk and sending a lot of email traffic around. That creates a record. It also can be challenging to communicate via email. So have your backroom and run it like you normally would.”

Closeout Meeting

Say you get through your inspection and you have had a great virtual inspection. You have given all the requested documents. You have answered all the questions. And now it is time for your closeout.

“We would hope that if you are having a virtual inspection and there is going to be a 483 issued that you are going to get a closeout meeting. I certainly would not expect them to put a 483 in the mail or the email with no discussion.”

To prepare for the closeout meeting:

  • Assume that you are going to get a closeout meeting. (You want to make sure only those who are necessary are in the room. They are going to want to issue the 483 to the most responsible individual at the site. That person must be around to receive the 483 if one is issued.)
  • Make sure you know who is going to be in the room.
  • Make sure you are taking accurate notes.

During the Meeting

Listen closely, particularly, if they are giving you verbal warnings or discussing items that are not written on the 483 for you to go back and refer to. You want to make sure you have a really good record of that so that you can address those as well.

“Again, do not argue an observation,” Chase recommended. “Now is not the time to be argumentative. If the 483 contains incorrect information, politely tell them you think that there is a mistake. For example, ‘I think it is supposed to be lot number one, two, three, not X, Y, Z.’ That way they can change it.  There is nothing wrong with doing that. You do not want the 483 to be incorrect. They do not want it to be either.”

‘Again, do not argue an observation,’ Chase recommended. ‘Now is not the time to be argumentative. If the 483 contains incorrect information, politely tell them you think that there is a mistake.’

If you do disagree with an observation, you can state why you disagree. But do not be argumentative. Just clearly state why you do not think the investigator is right. Do you not expect the investigator to change the 483. “They might listen to you. They might take notes on it. They might report it in their Establishment Inspection Report (EIR). But it does not mean that they are going to go back and change the 483. Be aware of that.”

Follow your policy for responding to a 483 if one is issued. You must ensure that your team and your leadership receive the 483 as soon as the inspection is over. You have a deadline. You want to hit that 15 business day deadline with a solid response. Make sure that you communicate very quickly with your team and your leadership so that you can get started on that if you do get a 483.

If you made some corrections during the inspection it is perfectly fine to ask if you can present those during the closeout. Hopefully, the investigator will be open to that. They will take some notes and put that in the report.

“Finally, do not ask the investigator what they are recommending—for example, voluntary action indicated (VAI) or official action indicated (OAI). By policy, they do not have the authority to answer that question. So do not ask them.”

There are many options for FDA when they conduct a virtual inspection and there are a lot of ways that they can communicate with you. The key to being successful are the same things as previous in-person inspections:

  • You need a solid program of continuous quality improvement.
  • You need to make sure that you have ongoing inspection preparedness.
  • You need to train and practice with your team.
  • You need to anticipate where the pinch points are; we all know our weaknesses.
  • Make sure that your communication is clear, concise, and professional.
  • Practice your inspection process and follow your routine process so that it seems more natural to you.

“Communications and logistics are probably going to be your biggest challenges because this is just a whole new way of doing business,” Chase commented. “It is important that you check those things out now and that you are prepared and are not dealing with those problems when you get a virtual inspection.”

Get your 483 Observation Report

Changing Medical Device Regulations

Presented by Redica Systems 

What you will learn:

  • The latest developments regarding the EU MDR
  • Quality Systems requirements for medical devices
  • Regulatory updates affecting medical devices

Download the Special Report

Download your copy of THE FDA INSPECTION LANDSCAPE IN MID-2020 AND A LOOK AT VIRTUAL INSPECTION

In this summary we identify:

  • Trend analysis of FDA inspections through mid-2020
  • Strategies for preparing and hosting virtual inspections
  • New technologies to support remote inspections
Redica Systems Enforcement Analytics

Compare the enforcement history of your CDMOs.

Enter your email address and someone will contact you shortly to customize your report.

Redica Systems Enforcement Analytics

Monitor compliance at your Clinical Investigator sites.

Enter your email address and someone will contact you shortly to get you started.

Redica Systems Enforcement Analytics

Prepare for inspections of Clinical Investigator sites.

Enter your email address and someone will contact you shortly to provide more Clinical Investigator data about your sites.

Redica Systems Enforcement Analytics

Prepare for your next inspection.

Enter your email address and someone will contact you shortly to explore enforcement trends. 

Redica Systems Enforcement Analytics

Prepare for your next inspection.

Enter your email address and someone will contact you shortly to explore observations and trends. 

Redica Systems Enforcement Analytics

Prepare for your next inspection.

Enter your email address and someone will contact you shortly to run your custom report.

Redica Systems Enforcement Analytics

Get help choosing the right CRO.

Enter your email address and someone will contact you shortly to customize your insights.

Redica Systems Enforcement Analytics

Compare two companies of your choice.

Enter your email address and someone will contact you shortly to customize your report.

Download the Special Report

CDMO Comparison opt-in

In this summary we identify:

FY2018-FY2020 GMP data for Lonza & Catalent

Top GMP primary citations

Top FDA 483 observations

Redica Systems Enforcement Analytics

Evaluate Your CDMOs

Enter your email address and someone will contact you shortly to customize your report.

Panel Discussion – Remote Audits

Panel Discussion opt in image

Featuring Panelists:
—Barbara W. Unger, Unger Consulting, Inc.
—Jerry Chapman, Redica Systems
—Stephanie Gaulding, Pharmatech Associates

Who Will Benefit?
This session will be valuable to GMP quality, regulatory, compliance, and management personnel in FDA-regulated industries who want to have a conversation on remote audits and get to know what is going on in the industry.

Turning Failure into Success

Presented on Tuesday, April 27, 2021 by Steve Greer, Executive Coach, Genesis Assist, and former Quality Leader, Procter and Gamble

What you will learn:

  • How to use the Leadership SOS Model to transform quality culture
  • How to strengthen quality systems to eliminate human error
  • How to generate ideas on how to set your organization up for success for shareholders, FDA, and staff
Redica Systems Enforcement Analytics

Get Full Access to Redica Enforcement Analytics

Enter your email address and someone will contact you shortly to answer all of your questions and get you started.

Quality Management Systems for Small Pharma and Biotech Firms

Webinar: QMS for Small Pharma and Biotech Firms

Presented by Fenton Fong, Founder, Managing Director, & Principal at xCellarate

Get instant access to the webinar video and slides.

What you will learn:

  • Common challenges small pharma firms face when developing a QMS
    Recent enforcement trends involving the Quality Unit
    Impact of the COVID-19 pandemic

Download the Special Report

APAC ad

In this summary we identify:

GMP data from FY2017 to FY2020 for the Asia-Pacific region

Top 3 GMP primary and secondary citations

Top 3 483 observations

Download the Special Report

An Analysis Of MHRA’s Latest Annual GMP Inspection Deficiencies Report

In this summary we identify:

  • Data from 2019 UK MHRA Inspections
  • Trends from 2015, 2016, 2018, and 2019 inspections
  • Conclusions drawn from an analysis of drug inspection data

Experience the Power of Redica Systems

Redica_Vert_Periwinkle_RGB_Large

SEARCH Find the inspection records you want by inspector’s name, company name, site, city, country, etc.

WARNING LETTERS Easily search the largest database of FDA Warning Letters by date, company, FDA office, or subject

SITES Quickly assess inspection records including dates and inspectors across all of your sites

INSPECTIONS Complete list of FDA inspections by date, company, category, and country

Get Complete Access to the Redica Systems Platform

Please submit your email address and one of our team members will contact you shortly to answer all of your questions and get you started with the new Enforcement Analytics platform.

Redica Systems Enforcement Analytics

Compare the inspection history of your CDMO sites.

Enter your email address and someone will contact you shortly to customize your report.

Experience the Power of Redica Systems

Complete the form and one of our experts will reach out to you to schedule a demo and answer questions about our subscription options.

INDEX INFORMATION  Redica consolidates regulatory data in real-time on the single largest database for quality, safety, and compliance intelligence.

STRENGTHEN DATASETS Redica machine intelligence algorithms identify and triage risk signals to derive meaning from vast amounts of private and public data.

ANALYZE & INTERPRET PATTERNS Redica instantly models the customer-specific regulatory risks, trends, and opportunities that stand to fundamentally change compliance operations.

Download the Special Report

Combination Product Report

What You Will Learn from This Report:

The latest U.S. and European regulatory developments

The impact of smart combination products

How the EU MDR impacts drug-device combination products

Experience the Power of Redica Systems

Redica Systems Enforcement Analytics

Let us know who you are and we’ll be in touch to answer all of your questions and get you started.

Download the Special Report

5 GMP Case Studies Report

What You Will Learn from This Report:

In-depth analysis of the findings

Lessons learned

How companies can avoid similar shortcomings.

Experience the Power of Redica Systems

Redica Systems Expert Jerry Chapman to Present at SQA Annual Meeting

Index Information Redica consolidates regulatory data in real-time on the single largest database for quality, safety, and compliance intelligence.

Strengthen Datasets Redica machine intelligence algorithms identify and triage risk signals to derive meaning from vast amounts of private and public data.

Analyze & Interpret Patterns Redica instantly models the customer-specific regulatory risks, trends, and opportunities that stand to fundamentally change compliance operations.

Download the 510(k) Sample

What You Will Learn from This Sample:

See how a 510(k) submission is structured

Find out what information to include

Review correspondence between sponsor and FDA

Redica Systems Enforcement Analytics

Unlimited Access to Reports and Data

Enter your email address and someone will contact you shortly.

Download the Special Report

5 GMP Case Studies Report

What You Will Learn from This Report:

The first countrywide import alert issued by FDA

An inadequate deviation investigation

An inadequate product specifications and a product recall

Process validation issues at a CMO

A different perspective on process validation and the culpability of the quality unit

 

A.I. for Quality and Compliance Teams

August 3 webinar

Presented by Redica Systems Senior GMP Quality Expert Jerry Chapman

What you will learn:

  • A basic understanding of data sources, machine learning, NLP, and A.I. tools
  • Building and applying Expert Models
  • Two case studies, one on sterile manufacturing/503B and one on data integrity

Get the scoop on recent data integrity 483 observations!

  • FY 2020 Data Integrity 483 Observations
  • Data Integrity Observations for Human Drugs
  • Observations Falling Under GMP
  •  

Human Factors – Compliance and Applications

June webinar

Presented by Alison Sathe, Founder, Regulatory Mark & Valerie Fenster, Director of Insights and  Human Factors, Kaleidoscope Innovation 

What you will learn:

  • Human factors strategies from simple drug products to complex surgical devices
  • Primary and secondary labeling development and evaluation for usability
  • Human factors activities from product development to post-market
  • International strategies: expectations for human factors in regulatory submissions in international markets
Redica Systems Enforcement Analytics

Keep up with the latest Regulatory Developments on Clinical Trials

Enter your email address and someone will contact you shortly. 

Redica Systems Enforcement Analytics

Upgrade your inspection strategy.

Enter your email address and someone will contact you shortly to get the reports and analysis you need to prepare for your next inspection.

Redica Systems Enforcement Analytics

Save your team valuable time when using External Monitoring.

Enter your email address and someone will contact you shortly. 

Redica Systems Enforcement Analytics

Save time and Resources when using External Monitoring.

Enter your email address and someone will contact you shortly. 

Redica Systems Enforcement Analytics

Get immediate access to the news that matters to your sites.

Enter your email address and someone will contact you shortly. 

Redica Systems Enforcement Analytics

See how we can help you eliminate yet another spreadsheet.

Enter your email address and someone will contact you shortly. 

Redica Systems Enforcement Analytics

Stay ahead of changing regulations.

Enter your email address and someone will contact you shortly to get the data and analysis you need.

Redica Systems Enforcement Analytics

Upgrade your CDMO monitoring strategy.

Enter your email address and someone will contact you shortly to get the data and analysis you need.

Redica Systems Enforcement Analytics

Upgrade your CDMO management strategy.

Enter your email address and someone will contact you shortly to get the reports and analysis you need.

Experience the Power of Redica Systems

Redica Systems Enforcement Analytics

Sign up for your FREE account today and get instant access to Enforcement Analytics.

Redica Systems Enforcement Analytics

Upgrade your inspection strategy.

Enter your email address and someone will contact you shortly to get the reports and analysis you need.

Discover the power of the most comprehensive database of 483s in existence.

Our database of over 20,000 483s is retyped and tagged, making it easy to create an Observation Report in seconds.

Eliminate days of work and get your FREE personalized 483 Observation Report.